📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

The benzimidazole based drugs show good activity against T. gondii but poor activity against its proposed enoyl reductase enzyme target. (2014)

First Author: Wilkinson C

Attributed to: Core Capability for Chemistry Research - Leeds funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.bmcl.2013.12.066

PubMed Identifier: 24398298

Publication URI: http://europepmc.org/abstract/MED/24398298

Type: Journal Article/Review

Volume: 24

Parent Publication: Bioorganic & medicinal chemistry letters

Issue: 3

ISSN: 0960-894X